Delivery Order SPE2DR25D3504-SPE2DR26F7CT0
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,528.73 for Linezolid 600 mg tablets (20-count packaging) on September 12, 2025, with completion expected by September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Linezolid is a broad-spectrum antibiotic commonly used in military and federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 28, 2025, for 600 mg linezolid tablets in quantities of 20 per unit. This is a firm fixed-price contract with a ceiling value of $5,267.59 and an ultimate completion date of August 29, 2025. The contract was competitively awarded with no set-aside designation. Linezolid is an antibiotic used to treat serious bacterial...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Linezolid 600 mg tablets in quantities of 20 units, with a contract value of $1,199.23. This firm fixed-price delivery order was awarded on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,660.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Linezolid 600 mg tablets in quantities of 20 units. The contract, with an ultimate completion date of September 10, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Linezolid 600 mg tablets (quantity 20s) valued at $1,515.56 under a firm fixed-price contract. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a non-competitive delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,031.18 firm fixed price contract is for the delivery of 4566377190 Linezolid 100 mg/5 ml suspension, a pharmaceutical product used to treat infections. The contract has an ultimate completion date of November 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LINEZOLID 600 MG TABLET 20S. The contract has a firm fixed price of $1,670.37 and a completion date of May 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Linezolid 600 mg tablets, a medication used to treat certain bacterial infections. The award ceiling value is $1,545.26, and the contract is structured as a Firm Fixed Price Delivery Order with an ultimate completion date of February 3, 2025. This award is part of a larger Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LINEZOLID 600 MG TABLET 20S. The contract, valued at $12,003.54, was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order with a completion date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical awarded a $844 delivery order to Amerisourcebergen Drug Corp for 600 mg tablets of linezolid. As the prime contractor, Amerisourcebergen will deliver 20 tablets of the antibiotic to a facility in Conshohocken, Pennsylvania by July 10, 2023 to fulfill requirements under the Prime Vendor Program contract vehicle. No subcontractors or set aside designations were indicated. The order supports DLA Troop Support Medical's mission to procure and...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7CT0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Linezolid 100 mg/5 mL suspension in 150 mL quantities, with a ceiling value of $2,805.87. This firm fixed-price delivery order, with an ultimate completion date of January 28, 2026, was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally. This delivery order supports the Defense Logistics Agency's critical pharmaceutical supply mission for military treatment facilities and related federal healthcare programs. Linezolid is a broad-spectrum antibiotic essential for treating serious infections, including methicillin-resistant Staphylococcus aureus (MRSA), making it a vital component of military and veteran healthcare inventories. AmerisourceBergen's role as a major pharmaceutical distributor ensures efficient fulfillment of federal medical procurement requirements across multiple therapeutic domains through its established supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 1/26/26 |